The global liquid biopsy market is anticipated to see a significant increase in value; industry projections place its value at USD 10,938.6 million by 2033. This significant expansion is anticipated to be driven by a robust Compound Annual Growth Rate (CAGR) of 21.7% over the ensuing ten years (2023–2033). Liquid biopsy is a revolutionary non-invasive real-time cancer tracking and detection technology …
Tag Archives: Liquid Biopsy Market Trends
Global Liquid Biopsy Market Set for Explosive Growth with 21.7% CAGR Fueled by Forecasts US$ 10,938.6 Million Market Valuation by 2033.
The global liquid biopsy market is poised for a remarkable surge, with a projected value of US$10,938.6 million by 2033. This significant growth is anticipated to be fueled by a robust Compound Annual Growth Rate (CAGR) of 21.7% over the next decade (2023-2033). Tumor tissue is currently the gold standard for characterizing and diagnosing cancer. …
Liquid Biopsy Market Poised to Surge Beyond US$ 4,126 Million by 2032, Redefining Cancer Detection and Monitoring
By 2023, the liquid biopsy market sales is expected to bring in US$ 1,538.3 million in revenue worldwide. Our healthcare domain experts predict that liquid biopsy providers will see robust growth, with a projected $10,938.6 million in sales by 2033 and a compound annual growth rate of 21.7% until that year. One of the key …